CULLGEN
Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies. The company's services use protein degradation technology that focuses on selective degradation of disease-causing proteins, novel treatment for cancer, inflammatory and autoimmune diseases, including targets previously considered undruggable, enabling scientists with new means to develop novel therapeutic approaches for various diseases.
CULLGEN
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cullgen.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
66 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Typekit Squarespace Squarespace Hosted
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
ARGOBIO
Argobio SAS is a start-up studio for Therapeutics aiming to nurture and launch Biotech companies.
ArriVent Biopharma
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products.
Avalyn Pharma
Avalyn Pharma is a biopharma company that advances therapies for the treatment of Idiopathic Pulmonary Fibrosis.
Biosortia Microbiomics
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
Cajal Neuroscience
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Cardior Pharmaceuticals
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Catalent Pharma Solutions
Catalent provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies.
Dogma Therapeutics
Dogma is developing oral PCSK9 inhibitors to treat high cholesterol and cardiovascular disease. https://www.dogmatherapeutics.com/
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Genomic Prediction
Genomic Prediction provides advanced genetic testing for IVF.
Glycologix
Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.
GlyTech
GlyTech is a responsibility of the company to protect personal information in its business activities.
Igyxos
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Levo Therapeutics
Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Netherlands Translational Research Center B.V.
Netherlands Translational Research Center translates novel biological concepts on the treatment of diseases into small molecule drugs.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
PharmaTher
PharmaTher is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
Science Exchange
Science Exchange, the R&D Services Management company, empowers research organizations to accelerate science and drive innovation success
Sentinel Oncology
Sentinel Oncology is a drug discovery company specialising in the delivery of candidate drugs to treat diseases.
SUN bioscience
SUN bioscience creates advanced cell culture platforms.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Vibliome
Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.
Vicarius Pharma
Vicarius Pharma was founded to provide research-driven pharmaceutical
XellSmart
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.
Current Employees Featured
Founder
Investors List
Heights Capital Management
Heights Capital Management investment in Series B - Cullgen
South China Venture Capital
South China Venture Capital investment in Series B - Cullgen
MSA Capital
MSA Capital investment in Series B - Cullgen
Octagon Capital Partners
Octagon Capital Partners investment in Series B - Cullgen
3E Bioventures
3E Bioventures investment in Series B - Cullgen
Highlight Capital
Highlight Capital investment in Series A - Cullgen
Sequoia Capital China
Sequoia Capital China investment in Series A - Cullgen
GNI Group
GNI Group investment in Seed Round - Cullgen
Official Site Inspections
http://www.cullgen.com Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
